Order Article Reprints

Elmowafy M, Alruwaili NK, Shalaby K, Alharbi KS, Altowayan WM, Ahmad N, Zafar A, Elkomy M. Long-Acting Paliperidone Parenteral Formulations Based on Polycaprolactone Nanoparticles; the Influence of Stabilizer and Chitosan on In Vitro Release, Protein Adsorption, and Cytotoxicity. Pharmaceutics. 2020; 12(2):160. https://doi.org/10.3390/pharmaceutics12020160

Elmowafy, Mohammed, Nabil K. Alruwaili, Khaled Shalaby, Khalid S. Alharbi, Waleed M. Altowayan, Naveed Ahmad, Ameeduzzafar Zafar, and Mohammed Elkomy. 2020. "Long-Acting Paliperidone Parenteral Formulations Based on Polycaprolactone Nanoparticles; the Influence of Stabilizer and Chitosan on In Vitro Release, Protein Adsorption, and Cytotoxicity" Pharmaceutics 12, no. 2: 160. https://doi.org/10.3390/pharmaceutics12020160

Elmowafy, M., Alruwaili, N. K., Shalaby, K., Alharbi, K. S., Altowayan, W. M., Ahmad, N., Zafar, A., & Elkomy, M. (2020). Long-Acting Paliperidone Parenteral Formulations Based on Polycaprolactone Nanoparticles; the Influence of Stabilizer and Chitosan on In Vitro Release, Protein Adsorption, and Cytotoxicity. Pharmaceutics, 12(2), 160. https://doi.org/10.3390/pharmaceutics12020160